News
Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs
30.01.2017
Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs
A. R. Bagheri, S. Agarwal, J. Golenser, A. Greiner Global Challenges 2017, DOI: 10.1002/gch2.201600011.
A programmable release system with wide range of release profiles of the antimalarial artemisone (ART) from fibrous nanocarriers (NFN) is presented. This is achieved following a new paradigm of using ART-loaded NFN in infusion system of hydrophobic drug eluting nanocarriers, adapted to clinical applications. Very importantly, under these conditions ART did not degrade as it was observed in solution.